Adenosine A2a Receptor anticorps (C-Term)

N° du produit ABIN929402

L’anticorps Lapin Polyclonal anti-Adenosine A2a Receptor a été validé pour WB. Il convient pour détecter Adenosine A2a Receptor dans des échantillons de Humain.

Aperçu rapide pour Adenosine A2a Receptor anticorps (C-Term) (ABIN929402)

Antigène: Adenosine A2a Receptor (ADORA2A)

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Adenosine A2a Receptor est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-Adenosine A2a Receptor anticorps

Épitope: C-Term

Purification: Purified

Immunogène: ADORA2 A antibody was raised in rabbit using the C terminal of ADORA2 as the immunogen

Information d'application

Indications d'application: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

ADORA2A Blocking Peptide, (ABIN5611957), is also available for use as a blocking control in assays to test for specificity of this ADORA2A antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Détails sur Adenosine A2a Receptor

Antigène: Adenosine A2a Receptor (ADORA2A)

Autre désignation: ADORA2A

Sujet: ADORA2A is one of several receptor subtypes for adenosine. The activity of the protein, a G-protein coupled receptor family member, is mediated by G proteins which activate adenylyl cyclase. ADORA2A is abundant in basal ganglia, vasculature and platelets and it is a major target of caffeine. Synonyms: Polyclonal ADORA2A antibody, Anti-ADORA2A antibody, adenosine A2a receptor antibody, ADORA2 antibody, RDC8 antibody, hA2aR antibody.

Pathways: Neurotrophin Signaling Pathway, cAMP Metabolic Process, Synaptic Membrane, Feeding Behaviour, Cancer Immune Checkpoints